Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?

To: Tenchusatsu who wrote (1451553)	4/11/2024 2:50:26 PM
From: Qone0	Read Replies (1) \| Respond to of 1583865

There is a whole industry built around pump and dumps on small pharmaceutical companies. The real business model much like DJT is to sell stock. The business never really have a chance of getting FDA approval. Playing them is simple. They get a new drug they pump it until the FDA review date, then short it. The drug fails the FDA. So they raise more money after the stock craters and then get another drug. The buy point is when they get more funding. BLUE was the last one played. It was all the rage, until the FDA black boxed it's label. I'm sure there are many more. I just only trade index futures now mostly. Don't really scan for stocks unless I'm bored.